While Inspire Medical Systems Inc has underperformed by -32.35%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, INSP fell by -52.58%, with highs and lows ranging from $225.00 to $123.25, whereas the simple moving average fell by -47.01% in the last 200 days.
On August 05, 2025, Truist Downgraded Inspire Medical Systems Inc (NYSE: INSP) to Hold. A report published by KeyBanc Capital Markets on August 05, 2025, Downgraded its rating to ‘Sector Weight’ for INSP. JP Morgan also Downgraded INSP shares as ‘Neutral’, setting a target price of $110 on the company’s shares in a report dated August 05, 2025. BofA Securities November 20, 2024d the rating to Buy on November 20, 2024, and set its price target from $220 to $255. BofA Securities May 08, 2024d its ‘Buy’ rating to ‘Neutral’ for INSP, as published in its report on May 08, 2024. RBC Capital Mkts’s report from April 19, 2024 suggests a price prediction of $285 for INSP shares, giving the stock a ‘Outperform’ rating. Morgan Stanley also rated the stock as ‘Overweight’.
Analysis of Inspire Medical Systems Inc (INSP)
Further, the quarter-over-quarter increase in sales is 10.82%, showing a positive trend in the upcoming months.
There are several well-rounded types of analysis and research techniques that can be used to gain a clear view of Inspire Medical Systems Inc’s future performance, with equity being one of the most critical indicators. The goal here is to ensure that your current return on equity of 8.07% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 4.84, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
As an indicator of volatility for any stock, average volume can also be very valuable, and INSP is recording an average volume of 592.63K. On a monthly basis, the volatility of the stock is set at 4.78%, whereas on a weekly basis, it is put at 7.77%, with a loss of -32.16% over the past seven days. Furthermore, long-term investors anticipate a median target price of $152.60, showing growth from the present price of $87.91, which can serve as yet another indication of whether INSP is worth investing in or should be passed over.
How Do You Analyze Inspire Medical Systems Inc Shares?
Inspire Medical Systems Inc (INSP) is based in the USA and is one of the most prominent companies operating in the Medical Devices market. When comparing Inspire Medical Systems Inc shares with other companies under Healthcare, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 50.93, there is a growth in quarterly earnings of -137.80%.
Apart from looking at the fundamentals, you should also pay attention to the number of company employees who own shares. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 5.61%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 111.55% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
INSP shares are owned by institutional investors to the tune of 111.55% at present.
